Paying users zone. Data is hidden behind: .
Get 1-month access to Pfizer Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Common-Size Income Statement
Pfizer Inc., common-size consolidated income statement
|Income statement item||Description||The company|
|Operating income||The net result for the period of deducting operating expenses from operating revenues.||Pfizer Inc.’s operating income as a percentage of revenues decreased from 2018 to 2019 and from 2019 to 2020.|
|Income from continuing operations before (provision) benefit for taxes on income||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Pfizer Inc.’s income from continuing operations before (provision) benefit for taxes on income as a percentage of revenues increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.|
|Net income attributable to Pfizer Inc.||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Pfizer Inc.’s net income attributable to Pfizer Inc. as a percentage of revenues increased from 2018 to 2019 but then slightly decreased from 2019 to 2020 not reaching 2018 level.|